Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:


From Diagnosis to Treatment: The Evolution of SSc-ILD

Access Activity

Overview / Abstract:

Explore this 45-minute multi-media eNewsletter that will advance your understanding of systemic sclerosis interstitial lung disease (SSc-ILD) with Dr. Ganesh Raghu, Director of the University of Washington Interstitial Lung Disease/Sarcoid/Pulmonary Fibrosis Program.

While there have been significant advances in our understanding of SSc-ILD, there are important unmet needs that still must be addressed. These include improvements in the differential diagnosis, advances in therapy, appropriate application of pharmacotherapy, and communicating with patients to improve quality of life, which will be addressed in this activity. Perspectives from patient ambassadors are also included, highlighting their journey and the complexities of diagnosis, treatment, and quality of life.


Aug 27, 2020


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE, Respiratory Therapy CE



Credits / Hours




Presenters / Authors / Faculty

Ganesh Raghu, MD, FCCP, FACP
Professor of Medicine and Laboratory Medicine
Division of Pulmonary, Sleep & Critical Care Medicine
University of Washington
Director: Center for Interstitial Lung Diseases
Co-Director: Scleroderma Clinic
University of Washington Medical Center
Seattle, WA

This activity also featured two patients living with SSc-ILD: Patient A and Patient B

Activity Specialities / Related Topics

Dermatology, Family Medicine, Internal Medicine, Pathology, Primary Care, Pulmonary Medicine / COPD, Radiology / Imagery / Nuclear Medicine, Rheumatology / Arthritis

Sponsors / Supporters / Grant Providers

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Keywords / Search Terms

ACHL ILD, SSc-ILD, interstitial lung disease, systemic sclerosis, Ganesh Raghu, CME, CE, continuing education, continuing medical education, webinar, dermatology, rheumatology, respiratory therapy, pulmonology, nintedanib, pirfenidone, cyclophosphamide, mycophenolate mofetil, LOTUSS, SENSCIS, HRCT Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.